When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
It has been 10 months since we last looked at a developmental concern named Syros Pharmaceuticals and we promised we would keep an eye on developments.
Today, we revisit Syros as it has been advancing its pipeline and has some trial milestones on the horizon.
We update our investment thesis on this small-cap concern in the paragraphs below.